Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 14 months ago
Share
Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex
250 patients around the world
Available in
Argentina, Chile, United States, Spain
Insmed Incorporated
1
Research sites
250
Patients around the world
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
Sites
Centro Respiratorio Quilmes - Buenos Aires
Recruiting
View site
Hipolito Yrigoyen 856, Quilmes, Buenos Aires
Centro Respiratorio Quilmes - Buenos Aires
Recruiting
View site
Hipolito Yrigoyen 856, Quilmes, Buenos Aires
See details
Contact us
Contact us
Study
ENCORE
Sponsor
Insmed Incorporated
Study type
Interventional
Requirements
From 18 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT04677569
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent